Every Friday, we will share links to news, blogs, and anything else we find interesting. We can’t catch everything, so you are invited to self-promote in the comments!
S. comments on asexuality in the Bible.
News & Outreach
Addyi/Flibanserin, the first drug to treat HSDD, has been criticized in a new JAMA study. A JAMA editorial criticized the process by which the drug was approved. Bloomberg reports the bad news for Valeant Pharmaceuticals (autoplay).